These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16953206)

  • 1. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation.
    Miura Y; Narimatsu H; Kami M; Kusumi E; Matsumura T; Yuji K; Wake A; Miyakoshi S; Taniguchi S
    Bone Marrow Transplant; 2006 Oct; 38(8):577-9. PubMed ID: 16953206
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
    Castilla C; Pérez-Simón JA; Sanchez-Guijo FM; Díez-Campelo M; Ocio E; Pérez-Persona E; López-Villar O; Vazquez L; Caballero D; San Miguel JF
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):936-41. PubMed ID: 16920559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral beclomethasone dipropionate as an initial treatment for stages 1-2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation.
    Yamamoto H; Uchida N; Uchida Y; Nishida A; Ota H; Kageyama K; Nasu I; Wada S; Kaji D; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Matsuno N; Yamamoto G; Masuoka K; Izutsu K; Wake A; Yoneyama A; Makino S; Ito T; Hayashi M; Taniguchi S
    Ann Hematol; 2015 Dec; 94(12):2073-5. PubMed ID: 26374433
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.
    Iyer RV; Hahn T; Roy HN; Battiwalla M; Cooper M; Anderson B; Paplham P; Brown K; Bambach B; Segal BH; McCarthy PL
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):587-92. PubMed ID: 16041308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) group.
    Takashima S; Eto T; Shiratsuchi M; Hidaka M; Mori Y; Kato K; Kamezaki K; Oku S; Henzan H; Takase K; Matsushima T; Takenaka K; Iwasaki H; Miyamoto T; Akashi K; Teshima T
    Intern Med; 2014; 53(12):1315-20. PubMed ID: 24930650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
    Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
    Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-intensity umbilical cord blood transplant for older adult patients.
    Lim SH; Esler WV; Periman PO; Beggs D; Zhang Y; Townsend M
    Bone Marrow Transplant; 2008 Nov; 42(10):685-6. PubMed ID: 18711343
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges.
    Uchino M; Ogawa Y; Kawai M; Shimada H; Kameyama K; Okamoto S; Dogru M; Tsubota K
    Acta Ophthalmol Scand; 2006 Aug; 84(4):545-8. PubMed ID: 16879579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
    Sugimoto K; Narimatsu H; Kawase T; Iida H; Watanabe M; Kohno A; Kuwatsuka Y; Uchida T; Hamaguchi M; Terakura S; Naoe T; Matsuo K; Murata M; Sawa M; Miyamura K; Morishita Y;
    Bone Marrow Transplant; 2008 Apr; 41(8):729-36. PubMed ID: 18176617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
    Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
    Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperacute graft-vs.-host disease after related HLA-identical umbilical cord blood transplantation.
    Kuskonmaz B; Gocer S; Ersoy-Ewans S; Cetin Ozman F; Cetin M; Uckan D
    Pediatr Transplant; 2007 Nov; 11(7):818-20. PubMed ID: 17910666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asymmetric peripheral neuropathy following reduced-intensity cord blood transplantation].
    Sumi M; Ichikawa N; Sato S; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Dec; 49(12):1604-8. PubMed ID: 19110521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effect.
    Takami A; Takamatsu H; Yamazaki H; Ishiyama K; Okumura H; Ohata K; Konaka H; Asakura H; Namiki M; Nakao S
    Bone Marrow Transplant; 2006 Dec; 38(11):729-32. PubMed ID: 17028623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oral beclometasone dipropionate in the treatment of gastrointestinal Graft-versus-Host Disease.
    Doan PL; Chao NJ
    Drugs; 2009 Jul; 69(10):1339-50. PubMed ID: 19583452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible graft-versus-host disease involving the central nervous system soon after cord blood transplantation.
    Yamamoto H; Uchida N; Ishiwata K; Araoka H; Takagi S; Tsuji M; Kato D; Matsuhashi Y; Seo S; Matsuno N; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Am J Hematol; 2009 Nov; 84(11):764-6. PubMed ID: 19760796
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients.
    Matsumura T; Narimatsu H; Kami M; Yuji K; Kusumi E; Hori A; Murashige N; Tanaka Y; Masuoka K; Wake A; Miyakoshi S; Kanda Y; Taniguchi S
    Biol Blood Marrow Transplant; 2007 May; 13(5):577-83. PubMed ID: 17448917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
    Hockenbery DM; Cruickshank S; Rodell TC; Gooley T; Schuening F; Rowley S; David D; Brunvand M; Berryman B; Abhyankar S; Bouvier M; McDonald GB
    Blood; 2007 May; 109(10):4557-63. PubMed ID: 17244684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases.
    Uchida N; Wake A; Takagi S; Yamamoto H; Kato D; Matsuhashi Y; Matsumura T; Seo S; Matsuno N; Masuoka K; Kusumi E; Yuji K; Miyakoshi S; Matsuzaki M; Yoneyama A; Taniguchi S
    Biol Blood Marrow Transplant; 2008 May; 14(5):583-90. PubMed ID: 18410901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cord blood transplantation for adults.
    Brunstein CG; Wagner JE
    Vox Sang; 2006 Oct; 91(3):195-205. PubMed ID: 16958831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease.
    Prot-Labarthe S; Therrien R; Champagne MA; Duval M; Joubert C
    Bone Marrow Transplant; 2007 Aug; 40(3):295-6. PubMed ID: 17549052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.